SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 205249

                                   ----------

                                   FORM 10-QSB

[X]  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934 for the Quarterly Period Ended September 30, 2002.

[_]  Transition  Report  Pursuant  to  Section  13 or  15(d)  of the  Securities
     Exchange Act of 1934 for the  Transition  Period from  ________________  to
     ___________________.

                        Commission File Number 000-27592

                         ------------------------------

                             TECH LABORATORIES, INC.
                   -------------------------------------------
              (Exact name of Small Business issuer in its charter)
------------------------------------------------------- ----- ------------------
         New Jersey                              22-1436279
------------------------------------------------------- ----- ------------------
(State or other jurisdiction of       (I.R.S. Employer Identification No.)
 incorporation or organization)
------------------------------------------------------- ----- ------------------
 955 Belmont Avenue, North Haledon, NJ                07508
------------------------------------------------------- ----- ------------------
(Address of principal executive offices)            (zip code)
------------------------------------------------------- ----- ------------------

       Registrant's telephone number, including area code: (973) 427-5333

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                         Yes  [X]          No  [_]

     The number of shares of Common Stock, par value $.01 per share, outstanding
as of the latest practicable date: As of November 18, 2002, there were 5,522,416
shares outstanding.





                                                        Tech Laboratories, Inc.

                                                              FORM 10-QSB

                                                           Table of Contents


                                                                                                               
PART I.  FINANCIAL INFORMATION..................................................................................  1
Item 1.  Financial Statements...................................................................................  1
September 30, 2002 and 2001 Balance Sheet (unaudited)...........................................................  1
Statement of Operations For The Third Quarter and Nine Months Ended September 30, 2002 and 2001 (unaudited).....  3
Statement of Cash Flow For The Nine Months Ended September 30, 2002 and 2001 (unaudited)........................  4
Notes to Consolidated Financial Statements......................................................................  5
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations....................  9
Item 3.Controls and Procedures.................................................................................. 10

PART II. OTHER INFORMATION...................................................................................... 11
Item 1.Legal Proceedings.........................................................................................11
Item 3.Defaults Upon Senior Securities.......................................................................... 11
Item 6.Exhibits and Reports on Form 8-K......................................................................... 11


SIGNATURES...................................................................................................... 12






                                     PART I.

                              FINANCIAL INFORMATION

Item 1.  Financial Statements.

                             TECH LABORATORIES, INC.
                           September 30, 2002 and 2001
                                  Balance Sheet

                                   (unaudited)



                   ASSETS
                                                                        FOR THE NINE
                                                                        MONTHS ENDED
                                                                        SEPTEMBER 30,
                                                                   2002               2001
                                                                   ----               ----
Current Assets:
                                                                           
  Cash ..............................................        $   136,288         $ 1,293,298
  Marketable Securities .............................             40,000              56,103
  Accounts Receivable, Net of Allowance for
    Doubtful Accounts of $25,000 ....................             23,962             144,556
  Inventories .......................................          2,148,018           1,731,915
  Prepaid Expenses ..................................              6,303               6,503
                                                             -----------         -----------

                 Total Current Assets ...............        $ 2,354,571         $ 3,232,375

Property, Plant, and Equipment, at Cost
  Leasehold Improvements ............................              2,247               2,247
  Machinery, Equipment, and Instruments .............            607,971             539,771
  Furniture and Fixtures ............................            100,142              92,690
                                                             -----------         -----------

                 Total Property, Plant, and Equipment            710,360             634,708
       Less:  Accumulated Depreciation & Amortization           (397,448)           (366,569)
                                                             -----------         -----------

                 Net Property, Plant, and Equipment .        $   312,912         $   268,139
                                                             -----------         -----------

Other Assets ........................................        $    12,059         $    12,059
                                                             -----------         -----------

                 Total Assets .......................        $ 2,679,542         $ 3,512,573
                                                             ===========         ===========


              The accompanying notes are an integral part of these
                             financial statements.

                                      -1-




                             TECH LABORATORIES, INC.
                           September 30, 2002 and 2001
                                  Balance Sheet

                                   (unaudited)

                    LIABILITIES AND STOCKHOLDERS' INVESTMENTS



                                                                              FOR THE NINE
                                                                              MONTHS ENDED
                                                                               SEPTEMBER 30,
                                                                        2002               2001*
                                                                        ----               ----
Current Liabilities:
                                                                                 
  Defaulted Convertible Notes .............................        $ 1,133,339                --
  Current Portion of Long-Term Debt .......................             32,102              33,433
  Short-Term Loans Payable ................................             53,231              63,593
  Accounts Payable ........................................            135,731              36,868
  Other Liabilities .......................................             52,602              26,099
                                                                   -----------         -----------

                 Total Current Liabilities ................        $ 1,407,005         $   159,993
                                                                   -----------         -----------

       Long-Term Convertible Notes ........................               --           $ 1,221,046

Stockholders' Investment:
  Common Stock, $.01 Par Value;
  10,000,000 Shares Authorized in 2001,
  25,000,000 Shares Authorized in 2002:
       4,790,942 shares outstanding in 2001 and
       5,389,024 shares outstanding in 2002 ...............        $    49,848         $    48,409
  Less:  15,191 Shares Reacquired and
       Held in Treasury ...................................               (113)               (113)
                                                                   -----------         -----------

                                                                   $    49,735         $    48,296
                                                                   -----------         -----------

  Capital Contributed in Excess of Par Value ..............          4,407,949         $ 4,379,129
  Retained Earnings/(Accum. Deficit) ......................         (3,185,147)         (2,295,891)
                                                                   -----------         -----------
                                                                     1,272,537           2,131,534

                 Total Liabilities and Stockholders' Equity        $ 2,679,542         $ 3,512,573
                                                                   ===========         ===========


*RESTATED FOR PRIOR PERIOD ADJUSTMENT - SEE NOTE 13.
 --------------------------------------------------

              The accompanying notes are an integral part of these
                             financial statements.

                                      -2-




                             TECH LABORATORIES, INC.
                         Statement of Operations For The
                       Third Quarter and Nine Months Ended
                           September 30, 2002 and 2001

                                   (unaudited)




                                                               FOR THE THREE                         FOR THE NINE
                                                               MONTHS ENDED                          MONTHS ENDED
                                                               SEPTEMBER 30,                         SEPTEMBER 30,
                                                          2002             2001*                  2002               2001*
                                                          ----             -----                  ----               ----

                                                                                                      
Sales ........................................        $    42,597         $    81,802         $   337,286         $   442,280
                                                      -----------         -----------         -----------         -----------

Costs and Expenses:
  Cost of Sales ..............................             20,376              37,967             216,099             264,831
  Selling, General, and Administrative Expense            249,161             400,933             675,935             910,418
                                                      -----------         -----------         -----------         -----------

                                                          269,537             438,900             892,034           1,175,249
                                                      -----------         -----------         -----------         -----------

Income/(Loss) from Operations ................        $  (226,940)        $  (357,098)        $  (554,748)        $  (732,969)

Other Income (Expenses):
  Interest Income ............................                855              12,559               4,230              62,771
  Interest Expense ...........................            (18,122)            (26,129)            (59,137)            (76,633)
                                                      -----------         -----------         -----------         -----------
                                                          (17,267)            (13,570)            (54,907)            (13,862)

Income/(Loss) Before Income Taxes ............        $  (244,207)        $  (370,668)        $  (609,655)        $  (746,831)
Provision for Income Taxes ...................               --                  --                  --                  --
                                                      -----------         -----------         -----------         -----------

Net Income/(Loss) ............................        $  (244,207)        $  (370,668)        $  (609,655)        $  (746,831)

Retained Earnings/(Accum. Deficit), Beg. ......         (2,940,940)         (1,925,233)         (2,575,492)         (1,549,060)
                                                      -----------         -----------         -----------         -----------

Retained Earnings/(Accum. Deficit), End ......         (3,185,147)        $(2,295,891)         (3,185,147)        $(2,295,891)
                                                      -----------         -----------         -----------         -----------

Earnings Per Share ...........................        $     (0.04)        $     (0.08)        $     (0.11)        $     (0.16)
                                                      -----------         -----------         -----------         -----------






*RESTATED FOR PRIOR PERIOD ADJUSTMENT - SEE NOTE 13.

              The accompanying notes are an integral part of these
                             financial statements.

                                      -3-




                             TECH LABORATORIES, INC.

                         Statement of Cash Flow For The
                                Nine Months Ended
                           September 30, 2002 and 2001



                                   (unaudited)
                                                             2002               2001*
                                                          ----------         ----------
Cash Flow From (For) Operating Activities:
                                                                    
Net Income/(Loss) From Operations ...........        $    (609,655)        $  (746,831)
  Add/(Deduct) Items Not Affecting Cash:
     Depreciation/Amortization ................             23,548              24,018
     Stock Compensation .......................               --               160,450
  Changes in Operating Assets and Liabilities
     Marketable Securities ....................               --                 8,320
     Accounts Receivable ......................             88,238             (50,604)
     Inventories...............................            (72,539)            (445,077)
     Accounts Payable .........................             53,507               3,907
     Other Assets/Liabilities .................             45,040              15,136
                                                       -----------         -----------

Net Cash Flow For Operating Activities ........           (471,861)         (1,030,681)
                                                       -----------         -----------

Cash Flows From (For) Investing Activities
  Addition of Machinery and Equipment .........            (87,721)            (84,258)
                                                       -----------         -----------

Net Cash Flow From Investing Activities .......            (87,721)            (84,258)
                                                       -----------         -----------

Cash Flow From (For) Financing Activities:
  Acquisition/(Payment) of Short/Long-Term Debt           (197,633)           (282,517)
  Issuance of Common Stock ....................              1,500             167,308
                                                       -----------         -----------

Net Cash Flow From (For) Financing Activities .           (196,133)           (115,209)
                                                       -----------         -----------

Net Increase/(Decrease) in Cash ...............           (755,715)         (1,230,148)
Cash Balance Beginning of Year ................            892,003           2,523,446

Cash Balance End of Third Quarter .............            136,288         $ 1,293,298
                                                       -----------         -----------



*RESTATED FOR PRIOR PERIOD ADJUSTMENT - SEE NOTE 13.


SIGNIFICANT NON-CASH FINANCING ACTIVITIES:
-----------------------------------------

As of September 30, 2001, an aggregate of $296,130 of Convertible Long-Term Debt
was converted into Common Stock.

As of September 30, 2002, an aggregate of $373,730 of Convertible Long-Term Debt
was converted into Common Stock.

              The accompanying notes are an integral part of these
                             financial statements.

                                      -4-


                             TECH LABORATORIES, INC.

                              Notes to Consolidated
                              Financial Statements
                              For Nine Months Ended
                               September 30, 2002

                                   (unaudited)


(1)  Summary of Significant Accounting Policies.

     CASH - Includes Tech Labs' checking account at Hudson United Bank and money
market accounts at Prudential Securities and Bear Stearns.

     REVENUE  RECOGNITION  - Tech Labs  recognizes  all revenues when orders are
shipped.

     ACCOUNTS RECEIVABLE - Tech Labs recognizes sales when orders are shipped to
customers.  The allowance for bad debts is accrued based on a review of customer
accounts receivables aging.

     INVENTORIES - Inventories are valued at cost or market, whichever is lower.
The FIFO cost method is generally used to determine the cost of the inventories.
At December  31,  2001 a physical  inventory  was taken and tested.  No physical
inventory was taken on September 30, 2002.

     PROPERTY  AND  DEPRECIATION  - Additions  to  property  and  equipment  are
recorded at cost.  Depreciation is computed using the straight-line  method over
the estimated useful lives of the assets as follows:

        ASSETS                                    ESTIMATED USEFUL LIVES

        Machinery                                      5 to 7 years
        Furniture & Fixtures                           5 to 7 years

Maintenance  and  repairs  are  charged to  expenses  as  incurred.  The cost of
betterments is capitalized and depreciated at appropriate rates. Upon retirement
or other  disposition of property items,  cost and accumulated  depreciation are
removed from the accounts and any gain or loss is reflected in the  statement of
income.

     INCOME TAXES - Income tax expense is based on reported income, and deferred
tax credit is  provided  for  temporary  differences  between  book and  taxable
income.

     MARKETABLE  SECURITIES - The  marketable  securities  are a time deposit at
Hudson United Bank. The amount of this deposit was $40,000 at December 31, 2001,
and $40,000 at September 30, 2002.

(2)  Inventories. Inventories at December 31, 2001, and September 30, 2002, were
     as follows:

                                                       2001            2002
                                                   -----------     ------------
         Raw Materials & Finished Components       $  993,666       $ 1,095,044
         Work in Process & Finished Goods           1,081,813         1,052,974
                                                   ----------       -----------
                                                   $2,075,479       $ 2,148,018
                                                   ==========       ===========

                                      -5-



(3)  Income/(Loss) Per Share.

     Pursuant to the  provisions of SFAS No. 128,  "Earnings Per Share," the Net
Income/(Loss)  per share was calculated on the weighted average number of shares
outstanding for the first nine months and the third quarter of 2002.

     Fully Diluted  Earnings per share would be based on the assumed  conversion
of all convertible notes and all outstanding options and warrants.  However, due
to  Anti-Dilution,  these assumed  conversions have been excluded.

                                        Three Months Ended    Nine Months Ended
                                        SEPTEMBER 30, 2002    SEPTEMBER 30, 2002

Net Income for the Calculation of EPS        (244,207)              (609,655)
                                             --------               --------
Shares for Computation of EPS               5,389,024              5,389,024
                                            ---------              ---------

(4)  Income Taxes.

     Since the Company has an operating  loss  carryforward  of $3,150,073 as of
December 31, 2001, no interperiod tax allocation was made.

(5)  Current Portion of Long-Term Debt.

     Loans payable to banks were as follows for the periods indicated:



                                                INTEREST     CURRENT     NON-CURRENT
PERIOD ENDED               PAYEE                 RATE        AMOUNT        AMOUNT
------------               -----                 ----        ------        ------
                                                                
2001                   Hudson United Bank    Prime + 1.5%    $33,347          ---
March 31, 2002         Hudson United Bank    Prime + 1.5%    $33,074          ---
June 30, 2002          Hudson United Bank    Prime + 1.5%    $32,661          ---
September 30, 2002     Hudson United Bank    Prime + 1.5%    $32,102          ---


Marketable securities are pledged as collateral on the above loan.

(6)  Short-Term Loans Payable.

     Demand loans payable include loans from third parties. The outstanding loan
balance due as of December 31, 2001, was $63,789,  $53,427 as of March 31, 2002,
$49,872 as of June 30, 2002,  and $53,231 as of September  30, 2002.  The annual
interest  rate for these loans  ranged  between six percent (6%) and ten percent
(10%). In October of 1999, three short-term loans for a total of $200,000 at ten
percent (10%) annual interest were completed.  Certain contractual revenues were
pledged to secure these loans.  As of December 31, 2000,  $150,000 of such loans
were repaid; $50,000 remains outstanding and is due December 31, 2002.

(7)  Common Stock.

     In 1999,  Tech  Labs  filed a  registration  statement  with  respect  to a
self-underwritten  public  offering to raise  between  $2,000,000  (minimum) and
$3,500,000  (maximum).  This  offering was  completed on May 3, 2000,  for total
proceeds of $2,273,723.
                                      -6-

(8)  Commitments and Contingencies.

     In 1997, the Company  entered into an exclusive  agreement with  Elektronik
Apparatebau (EAG), FUA Safety Equipment,  and Double T Sports,  LTD., whereby it
received exclusive rights to manufacture and market IDS products until September
30, 2007, in the US, Canada, and South America. Gross profits will be calculated
according to GAAP and  distributed  quarterly  70% to the Company and 30% to FUA
until March 2001.  Thereafter,  until 2007, quarterly distribution will be based
on pretax  profits in excess of 15% being  shared 70% to the  Company and 30% to
FUA. In  addition,  FUA will  receive a 5% royalty  based on the cost of any IDS
products the Company manufactures and sells. Since 1997, sales and distributions
to FUA have been $1.4 million and $220,000.

(9)  Long-Term Convertible Debt.

     On October 13, 2000, the Company completed a $1.5 million financing of 6.5%
convertible  promissory  notes (the  "Convertible  Notes") due October 15, 2002.
Interest is payable quarterly in cash or in shares of common stock at the option
of the  noteholders.  The Company  disclosed all terms of this financing in Form
8-K filed on October 18, 2000. As of September  30, 2002,  $373,730 of principal
on the Convertible  Notes has been converted into shares of the Company's common
stock.

(10) On January 11, 2002,  the Company  entered into a redemption and conversion
agreement  concerning  the  Long-Term  Debt  referenced in Note (9). An Event of
Default,  as defined in the Convertible Notes occurred on January 25, 2002, when
the Company  was unable to make the first  payment of $750,000 to the holders of
the Notes.

     On April  19,  2002,  the  Company  successfully  negotiated  a cure of the
default  referenced  above.  This cure required that the Company's  registration
statement,  filed with the Securities and Exchange  Commission on April 5, 2002,
covering the shares underlying the Convertible  Notes, be declared  effective on
or  before  June 29,  2002.  If the  registration  statement  had been  declared
effective by such date and the Company made  certain  payments  described in the
Company's  report on Form 8-K filed April 25,  2002,  the  maturity  date of the
Convertible  Notes would have been  extended  from October 13, 2002, to December
30, 2002.

(11) Subsequent Events.

(A)  On August 2, 2002, the Company  announced that an Event of Default occurred
on the  Convertible  Notes.  The  Company  was  unable to have its  registration
statement  declared  effective by June 29,  2002,  and was unable to reach a new
agreement with the holders of the  Convertible  Notes prior to the expiration of
the waiver the  Company  had been  granted  by the  noteholders,  which had been
granted in order to permit the parties  time to negotiate a new  agreement.  The
Company  continues  to seek a cure  for the  default  with  the  holders  of the
Convertible Notes.

(B) On November 13, 2002, the Company  received a letter from one of the holders
of the Convertible  Notes  demanding  payment on November 30, 2002 of liquidated
damages in the amount of $40,700 and accrued interest on its Convertible Note of
$51,762.

(12) Going Concern.

     As a result of operating losses and negative cash flows experienced  during
2001 and  2002,  Tech  Labs has a tenuous  liquidity  position.  If sales do not
improve or alternate  financing is not obtained,  substantial doubt exists about
the Company's ability to continue as a going concern.

                                      -7-



(13) Prior Period Adjustment.

     Over the course of 2001, Tech Labs issued and distributed 170,000 shares of
common  stock  to Mr.  Barry  Bendett  pursuant  to the  terms  of a  consulting
agreement  the  Company  entered  into with Mr.  Bendett on November  13,  2000.
Valuing these shares at their market value on their respective dates of issuance
and distribution, Tech Labs should have expensed $168,950. This compensation was
never expensed. This error is corrected as follows:

FULL YEAR 2001
--------------

                                                                                      
Closing Balance Retained Earnings as reported                                            $(2,406,542)
Adjustment referenced above                                                                 (168,950)
                                                                                            ---------

Revised December 31, 2001, Closing Balance of Retained Earnings                          $(2,575,492)

Net Loss first nine months 2002                                                             (609,655)
                                                                                        -------------

June 30, 2002, Retained Earnings after Prior Period Adjustment                           $(3,185,147)
                                                                                         ============


     For  comparative  purposes,  the nine months ended September 30, 2001, have
been  re-stated  and  are  so  noted  in  the  Company's   financial   statement
presentation in this Form 10-QSB.



                                      -8-




Item 2. Management's  Discussion and Analysis of Financial Condition and Results
           of Operations.

     The  information  contained in this section  should be read in  conjunction
with the Consolidated  Financial  Statements and Notes thereto appearing in this
report Form 10-QSB and the Company's  Annual Report for the year ended  December
31, 2001.

     QUARTER ENDING SEPTEMBER 30, 2002, COMPARED TO QUARTER ENDING SEPTEMBER 30,
     ---------------------------------------------------------------------------
2001.
----
     Sales were $42,597 for the third quarter of 2002 as compared to $81,802 for
the similar  period of 2001.  This decrease is due to the Company  suffering the
effects of the economic downturn which began in 2001.

     Cost of sales of $20,376 for the third  quarter of 2002 declined by $14,591
compared  to the same  period  of 2001,  primarily  due to sales  declines.  The
Company  has  reduced   factory   payroll  to  the  bare   minimum  but  remains
operationally viable.

     Selling,  administrative,   and  general  expenses  decreased  by  $151,772
compared to the same period of 2001 due to severe  reductions  in SG&A  payroll,
legal fees, and outside consulting fees.

     Income from operations of ($244,207)  increased $126,461 compared to a loss
of  ($370,668)  for the prior period as a direct  result of the Company  cutting
factory and SG&A  payroll.  The Company is  essentially  operating  in a minimum
expense mode, and will continue to do so until the downturn ends.

     NINE MONTHS ENDING SEPTEMBER 30, 2002, COMPARED TO YEAR ENDING DECEMBER 31,
     ---------------------------------------------------------------------------
2001.
-----
SIGNIFICANT CHANGES

     During the first nine months of 2002, the Company  continues to suffer from
the current economic downturn.

     Cash Flow for the first nine months of 2002 was  negative  ($755,715)  as a
result of the economic downturn.

LIQUIDITY AND CAPITAL RESOURCES

     The Company's  operating  activities utilized cash of $(471,861) during the
nine  months  ended  September  30,  2002,  as  compared  to  utilizing  cash of
$(1,030,681) during the nine months ended September 30, 2001.

     During the first nine months of 2002, as a result of the economic downturn,
the Company  suffered  severe  operating  losses and  negative  cash flows which
impaired  its  liquidity  position  and caused the Company to default on certain
convertible  notes  issued in  October  2000.  As of  September  30,  2002,  the
outstanding balance owed on the convertible notes was $1,133,339.

     As a result of operating losses and negative cash flow  experienced  during
2002,  Tech Labs has a tenuous  liquidity  position.  If sales do not improve or
alternative financing is not obtained, substantial doubt exists about Tech Labs'
ability to continue as a going concern.

                                      -9-



Item 3. Controls and Procedures.

     (a)  Evaluation of disclosure controls and provisions.

          Based on their  evaluation of our  disclosure  controls and procedures
     conducted within ninety (90) days of the date of filing this report on Form
     10-Q,  our  Chief  Executive  Officer  and  Chief  Financial  Officer  have
     concluded that our disclosure  controls and procedures (as defined in Rules
     13a - 14(c) and 15d - 14(c) promulgated  under the Securities  Exchange Act
     of 1934) are effective.

     (b)  Changes in internal controls.

          There were no significant changes in our internal controls or in other
     factors that could  significangly  affect these controls  subsequent to the
     date of their evaluation.



                                      -10-




                                    PART II.

                                OTHER INFORMATION

Item 1. Legal Proceedings.

     On July 31,  2002,  Tawfik  Khalil and Amneh  Khalil filed a lawsuit in the
Superior  Court of Passaic  County,  New Jersey,  against Glen Venza,  a Company
employee, Tech Labs, and certain other parties for property damages and personal
injuries.  The case  arose  from a car  accident  involving  Mr.  Venza  and the
plaintiffs,  which occurred  while Mr. Venza was  performing  certain duties for
Tech Labs in a vehicle Mr. Venza borrowed from a third party. Tech Labs has only
been named as a party to the personal  injuries,  and not for property  damages,
and believes it is covered for the accident by its insurance policy.

Item 3. Defaults Upon Senior Securities.

     On August 2, 2002, the Company  announced that an Event of Default occurred
under the terms of the  Convertible  Notes.  The  Company was unable to have its
registration statement filed April 5, 2002, declared effective by June 29, 2002,
as required by the terms of the amended redemption and conversion  agreement the
Company  entered  into  with the  noteholders  on April 19,  2002 (the  "Amended
Redemption  Agreement"),  and was  unable  to  reach a new  agreement  with  the
noteholders of the  Convertible  Notes prior to the expiration of the waiver the
Company had been granted by the noteholders,  which had been granted in order to
permit the parties time to negotiate a new agreement.

     Under the terms of the  Convertible  Notes,  the  Company  is  required  to
maintain  an  effective  registration  statement  covering  the  shares  of  the
Company's common stock underlying the Convertible  Notes. Under the terms of the
Amended Redemption  Agreement,  the Company had until June 29, 2002, in order to
have its registration statement declared effective.

Item 6. Exhibits and Reports on Form 8-K.

(a)      Exhibits

     99.1  Certification  of the Chief Executive and Chief Financial  Officer of
the Company pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(b)      Reports on Form 8-K.

     On July 8, 2002,  the Company filed a current  report on Form 8-K reporting
under Item V (Other Events) that the Company  issued a press release  announcing
that it had  entered  into an  agreement  pursuant  to which the  holders of its
Convertible  Notes  agreed to waive any defaults  until July 15, 2002,  that may
otherwise have occurred under the Amended Redemption Agreement in order to allow
the parties time to negotiate revised terms of their agreement.

     On July 18, 2002,  the Company filed a current report on Form 8-K reporting
under Item V (Other Events) that the Company  issued a press release  announcing
that it had  entered  into an  agreement  pursuant  to which the  holders of its
Convertible  Notes  agreed to waive any defaults  until July 30, 2002,  that may
otherwise have occurred under the Amended Redemption Agreement in order to allow
the parties time to negotiate revised terms of their agreement.

     On August 6, 2002, the Company filed a current report on Form 8-K reporting
under Item V (Other Events) that the Company  issued a press release  announcing
that an Event of Default occurred under its outstanding  Convertible  Cotes. The
Event of Default  occurred  due to the fact that the waiver the Company had been
granted by noteholders  waiving any event of default under the notes,  including
the  requirement  to have  declared  effective on or before June 29,  2002,  the
registration  statement covering the shares underlying the Convertible Notes had
expired without the Company and the noteholders having reached a new agreement.
                                      -11-




                             TECH LABORATORIES, INC.

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

Date:    November 19, 2002

                                             TECH LABORATORIES, INC.



                                             By: /S/ BERNARD M. CIONGOLI
                                                 -------------------------------
                                                 Bernard M. Ciongoli
                                                 Chief Financial Officer
         (Principal Financial Officer and Chief Accounting Officer)



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, Bernard M.  Ciongoli,  President,  Chief  Executive  Officer,  and Chief
Financial Officer of Tech Laboratories, Inc. certify that:

1.   I  have  reviewed  this  quarterly   report  on  Form  10-Q  for  the  Tech
     Laboratories, Inc.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this quarterly report.

3.   Based  on my  knowledge,  the  financial  statements  and  other  financial
     information  included  in this  quarterly  report,  fairly  present  in all
     material respects the financial condition,  results of operation,  and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     quarterly report.

4.   The  registrant's  other  certifying  officers  and I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     (a)  designed  such  disclosure  controls  and  procedures  to ensure  that
          material  information  relating  to  the  registrant,   including  its
          consolidated subsidiaries,  is made known to us by others within those
          entities,  particularly  during  the  period in which  this  quarterly
          report is being prepared;
                                     -12-

     (b)  evaluated the  effectiveness of the registrant's  disclosure  controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and

     (c)  presented  in  this  quarterly   report  our  conclusions   about  the
          effectiveness  of the disclosure  controls and procedures based on our
          evaluation as of the Evaluation Date.

5.   The registrant's other certifying  officers and I have disclosed,  based on
     our most recent  evaluation,  to the  registrant's  auditors  and the audit
     committee of the registrant's board of directors (or persons performing the
     equivalent function):

     (a)  all  significant  deficiencies  in the design or operation of internal
          controls  which could  adversely  affect the  registrant's  ability to
          record,  process,  summarize,  and  report  financial  data  and  have
          identified for the  registrant's  auditors any material  weaknesses in
          internal controls; and

     (b)  any fraud, whether or not material,  that involves management or other
          employees who have a  significant  role in the  registrant's  internal
          controls.

6.   The  registrant's  other  certifying  officers and I have indicated in this
     quarterly report whether or not there were significant  changes in internal
     controls  or in other  factors  that could  significantly  affect  internal
     controls  subsequent to the date of our most recent  evaluation,  including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

Date:    November 19, 2002


               By: /S/ BERNARD M. CIONGOLI
               --------------------------------------------------
               President, Chief Executive Officer, and Chief Financial Officer




                                      -13-





                                                                   Exhibit 99.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of Tech  Laboratories,  Inc.  (the
"Company") on Form 10-Q for the quarter ended  September 30, 2002, as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Bernard M. Ciongoli,  President,  Chief Executive  Officer,  and Chief Financial
Officer of the Company,  certify,  pursuant to 18 U.S.C.  ss.  1350,  as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

1.   The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.


/S/ BERNARD M. CIONGOLI
-----------------------
Bernard M. Ciongoli
President, Chief Executive Officer, and Chief Financial Officer

November 19, 2002


                                      -14-